JP Patent

JP7849520B2 — 含窒素架橋複素環誘導体の薬学的に許容される塩、結晶形及びその調製方法

Assigned to Shanghai Hengrui Pharmaceutical Co Ltd · Expires 2026-04-21 · 0y expired

What this patent protects

Patent listed against iptacopan-hydrochloride.

Drugs covered by this patent

iptacopan-hydrochloride (IPTACOPAN HYDROCHLORIDE)

Patent Metadata

Patent number: JP7849520B2
Jurisdiction: JP
Classification: —
Expires: 2026-04-21
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Hengrui Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.